Aberrant MUC Immunohistochemical Expressions in Inflammatory Bowel Diseases

被引：2

作者：

Hamamoto, Yuichiro ^{[1
,3
,5
]}

Kawamura, Michihiro ^{[2
]}

Uchida, Hiroki ^{[2
]}

Takagahara, Kojiro ^{[2
]}

Katori, Chiaki ^{[2
]}

Asai, Hinako ^{[2
]}

Harada, Hiroshi ^{[1
]}

Shimizu, Shigeki ^{[4
]}

Morii, Eiichi ^{[3
]}

Yoshida, Kyotaro ^{[1
,2
]}

机构：

[1] Kinki Cent Hosp, Dept Diagnost Pathol, Itami, Hyogo, Japan

[2] Kinki Cent Hosp, Dept Clin Lab, Itami, Hyogo, Japan

[3] Osaka Univ, Dept Pathol, Grad Sch Med, Suita, Japan

[4] Natl Hosp Org Kinki Chuo Chest Med Ctr, Dept Clin Lab, Kita Ku, Osaka, Japan

[5] Kinki Cent Hosp, Dept Diagnost Pathol, 3-1 Kurumaduka,, Itami, Hyogo 6648533, Japan

来源：

APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY | 2023年 / 31卷 / 02期

关键词：

mucin; MUC; ulcerative colitis; crohn disease; ischemic colitis; inflammatory bowel disease; immunohistochemistry; ULCERATIVE-COLITIS; BARRIER;

D O I：

10.1097/PAI.0000000000001096

中图分类号：

R602 [外科病理学、解剖学]; R32 [人体形态学];

学科分类号：

100101 ;

摘要：

Ulcerative colitis (UC) and Crohn disease (CD) are cryptogenic inflammatory bowel diseases that are suggestive of aberrant mucin (MUC) expression; however, their relationship remains unclear. Here, we examined aberrant MUC expression in intestinal samples from UC and CD patients in comparison to samples from patients with ischemic colitis and control groups. To study the expression of MUC1, MUC5AC, and MUC6 in different patient groups, we reviewed the slides stained with hematoxylin and eosin and performed immunohistochemistry. The results revealed that MUC1 was expressed more in the UC group and MUC6 in the CD group. No significant changes were observed in MUC expression in the ischemic colitis group. Overall, we demonstrated changes in MUC expression in UC and CD, which can help in the diagnosis and early clinical management of UC and CD.

引用

页码：107 / 112

页数：6

共 50 条

[41] Etiopathogenesis of inflammatory bowel diseases
Danese, Silvio
Fiocchi, Claudio
WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (30) : 4807 - 4812
[42] BACTERIA AND INFLAMMATORY BOWEL DISEASES
FAHRLANDER, H
THERAPEUTISCHE UMSCHAU, 1980, 37 (03) : 198 - 200
[43] CHRONIC INFLAMMATORY BOWEL DISEASES
VANTONGEREN, JHM
TGO-TIJDSCHRIFT VOOR THERAPIE GENEESMIDDEL EN ONDERZOEK JDR-JOURNAL FOR DRUGTHERAPY AND RESEARCH, 1984, 9 (05): : 228 - 231
[44] Biomarkers in inflammatory bowel diseases
Roblin, Xavier
Cavaille, Alaric
Clavel, Lea
Paul, Stephane
PRESSE MEDICALE, 2014, 43 (01): : 66 - 73
[45] NUTRITION IN INFLAMMATORY BOWEL DISEASES
Mihai, Catalina
Prelipcean, Cristina Cijevschi
Pintilie, Iulia
Nedelciuc, Otilia
Jigaranu, Anca-Olivia
Dranga, Mihaela
Mihai, B.
MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2013, 117 (03): : 662 - 669
[46] OSTEOPENIA IN INFLAMMATORY BOWEL DISEASES
TROMM, A
RICKELS, K
HUPPE, D
WIEBE, V
MAY, B
LEBER MAGEN DARM, 1994, 24 (01) : 23 - &
[47] Prebiotics in inflammatory bowel diseases
Guarner, Francisco
BRITISH JOURNAL OF NUTRITION, 2007, 98 : S85 - S89
[48] Pancreatitis in Inflammatory Bowel Diseases
Pitchumoni, C. S.
Rubin, Amy
Das, Kiron
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2010, 44 (04) : 246 - 253
[49] Pathophysiology of Inflammatory Bowel Diseases
Chen, Chung-Jen
Hu, Huangming
Liao, Wei-Ting
Gaffney, Peter
Gaffney, Robert
Mravec, Boris
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (14): : 1376 - 1378
[50] Antibiotics and Inflammatory Bowel Diseases
Scribano, Maria Lia
Prantera, Cosimo
DIGESTIVE DISEASES, 2013, 31 (3-4) : 379 - 384

← 1 2 3 4 5 →